The ECV day-1 outcome for Atrial Fibrillation data collection: a retrospective analysis of outcomes on day-1 after electrical cardioversion

Electrical cardioversion (ECV) is an effective treatment for patients with AF, restoring sinus rhythm in approximately 90% of cases.The Amsterdam University Medical Center (Amsterdam UMC), location AMC, treats more than 500 patients with an elective ECV, per year. If the patients feel well enough, they are discharged to their home environment, under supervision for the first evening and night.

Research question
Is it safe for patients who have undergone an elective ECV in the AMC, to spend the first evening and night alone at home, without additional supervision?

For this retrospective outcome analysis, “safe” is defined as the absence of complications related to the anaesthesia or the cardioversion, in the first 24 hours after the ECV procedure.

Is it safe for patients who have undergone an elective ECV in the AMC, to spend the first evening and night alone at home, without additional supervision?

Timepoint 1: Baseline measurements: cardiac rate, rhythm, and other cardiac variables, before ECV.
Timepoint 2: 0-2 hours after ECV: cardiac rate and rhythm, adverse events or complications, their type, severity, treatment, and outcome, measured until discharge from hospital.
Timepoint 3: 2-24 hours: any adverse events or complications as a result of the anesthesia or ECV, their type, severity, treatment, and outcome, measured from discharge until 24 hours after ECV.
Timepoint 4: 30 days: Any adverse events or complications as a result of the anesthesia or ECV, their type, severity, treatment, and outcome, measured between 24 hours and one month after the procedure.

None, observational